These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 25522073)

  • 21. The effect of mandatory generic substitution on the safety of alendronate and patients' adherence.
    Lai PS; Chua SS; Chong YH; Chan SP
    Curr Med Res Opin; 2012 Aug; 28(8):1347-55. PubMed ID: 22746354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of switching from branded to generic antiretrovirals in virologically suppressed HIV-infected patients.
    Gianotti N; Poli A; Galli L; Franzin M; Tadini P; Galizzi N; Carbone A; Merli M; Muccini C; Oltolini C; Andolina A; Spagnuolo V; Lazzarin A; Castagna A
    PLoS One; 2017; 12(8):e0182007. PubMed ID: 28763473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The changing patterns of dispensing branded and generic drugs for the treatment of gastroesophageal reflux disease between 2006 and 2011 in Japan: a retrospective cohort study.
    Murata K; Hinotsu S; Hamada S; Ezoe Y; Muto M; Kawakami K
    BMC Health Serv Res; 2015 Feb; 15():76. PubMed ID: 25885571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of increased adherence and cost savings of an employer value-based benefits program targeting generic antihyperlipidemic and antidiabetic medications.
    Clark B; DuChane J; Hou J; Rubinstein E; McMurray J; Duncan I
    J Manag Care Pharm; 2014 Feb; 20(2):141-50. PubMed ID: 24456315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Associations between generic substitution and patients' attitudes, beliefs and experiences.
    Rathe J; Larsen P; Andersen M; Paulsen M; Jarbøl D; Thomsen J; Soendergaard J
    Eur J Clin Pharmacol; 2013 Oct; 69(10):1827-36. PubMed ID: 23765409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Do users of risperidone who switch brands because of generic reference pricing fare better or worse than non-switchers? A New Zealand natural experiment.
    Lessing C; Ashton T; Davis P
    Adm Policy Ment Health; 2015 Nov; 42(6):695-703. PubMed ID: 25331449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of generic substitution on refill adherence to statin therapy: a nationwide population-based study.
    Trusell H; Sundell KA
    BMC Health Serv Res; 2014 Dec; 14():626. PubMed ID: 25475416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrapatient variation in antiepileptic drug plasma concentration after generic substitution vs stable brand-name drug regimens.
    Contin M; Alberghini L; Candela C; Benini G; Riva R
    Epilepsy Res; 2016 May; 122():79-83. PubMed ID: 26987080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adherence to a fixed-dose combination of rosiglitazone maleate/metformin hydrochloride in subjects with type 2 diabetes mellitus: a retrospective database analysis.
    Vanderpoel DR; Hussein MA; Watson-Heidari T; Perry A
    Clin Ther; 2004 Dec; 26(12):2066-75. PubMed ID: 15823770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of costs of Medicare Part D prescriptions dispensed at retail and mail order pharmacies.
    Carroll NV
    J Manag Care Spec Pharm; 2014 Sep; 20(9):959-67. PubMed ID: 25166295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between dispensing channel and medication adherence among medicare beneficiaries taking medications to treat diabetes, high blood pressure, or high blood cholesterol.
    Iyengar RN; Balagere DS; Henderson RR; LeFrancois AL; Rabbitt RM; Frazee SG
    J Manag Care Spec Pharm; 2014 Aug; 20(8):851-61. PubMed ID: 25062079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences in rates of switchbacks after switching from branded to authorized generic and branded to generic drug products: cohort study.
    Desai RJ; Sarpatwari A; Dejene S; Khan NF; Lii J; Rogers JR; Dutcher SK; Raofi S; Bohn J; Connolly J; Fischer MA; Kesselheim AS; Gagne JJ
    BMJ; 2018 Apr; 361():k1180. PubMed ID: 29615391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential Clinical and Economic Impact of Switching Branded Medications to Generics.
    Straka RJ; Keohane DJ; Liu LZ
    Am J Ther; 2017 May; 24(3):e278-e289. PubMed ID: 26099048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generic substitution: additional challenge for adherence in hypertensive patients?
    Håkonsen H; Eilertsen M; Borge H; Toverud EL
    Curr Med Res Opin; 2009 Oct; 25(10):2515-21. PubMed ID: 19708764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Switching From High-Efficacy Lipid-Lowering Therapies to Generic Simvastatin on LDL-C Levels and LDL-C Goal Attainment Among High-Risk Primary and Secondary Prevention Populations in the United Kingdom.
    Cao X; Ejzykowicz F; Ramey DR; Sajjan S; Ambegaonkar BM; Mavros P; Tunceli K
    Clin Ther; 2015 Apr; 37(4):804-15. PubMed ID: 25626487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Healthcare costs and prescription adherence with introduction of thiazolidinedione therapy in Medicaid type 2 diabetic patients: a retrospective data analysis.
    Balkrishnan R; Rajagopalan R; Shenolikar RA; Camacho FT; Whitmire JT; Anderson RT
    Curr Med Res Opin; 2004 Oct; 20(10):1633-40. PubMed ID: 15462696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generic substitution of commonly used medications: Australia-wide experience, 2007-2008.
    Ortiz M; Simons LA; Calcino G
    Med J Aust; 2010 Apr; 192(7):370-3. PubMed ID: 20367581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug switching in the Netherlands: a cohort study of 20 active substances.
    Glerum PJ; Maliepaard M; de Valk V; Burger DM; Neef K
    BMC Health Serv Res; 2020 Jul; 20(1):650. PubMed ID: 32660480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adherence to oral antidiabetic medications in the pediatric population with type 2 diabetes: a retrospective database analysis.
    Adeyemi AO; Rascati KL; Lawson KA; Strassels SA
    Clin Ther; 2012 Mar; 34(3):712-9. PubMed ID: 22381712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patient, physician, pharmacy, and pharmacy benefit design factors related to generic medication use.
    Shrank WH; Stedman M; Ettner SL; DeLapp D; Dirstine J; Brookhart MA; Fischer MA; Avorn J; Asch SM
    J Gen Intern Med; 2007 Sep; 22(9):1298-304. PubMed ID: 17647066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.